Neurocentrx

Developing products to treat chronic cancer pain.

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2013 groups4 employees language neurocentrx.com

Registered entities

Social engagement

Social engagement: 991 social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital233%
Angel & family office117%
Other / undisclosed350%

Recent activity

24 Apr 2026
Event
Reimagining Ketamine Delivery for Scale Panel
5 Dec 2025
Milestone
regulatory
Coming soon